ZRO BIOSENTA Inc

Biosenta, Inc. (CNSX:ZRO) ("Biosenta" or the "Company") is pleased to announce
the appointment of Chris Bilz to the position of President & CEO effective
immediately. Mr. Bilz's role will be to oversee the development of the Company's
production and distribution facilities, as well as the sales and marketing
infrastructure in Canada and the United States.


Biosenta also announced that Mr. Bruce Lewis has been appointed Chairman of the
Company's board of directors.


Mr. Bilz, brings a wide range of business and entrepreneurial experience to his
position with Biosenta, including 10 years experience with a Canadian bank in
the wealth management and capital markets sectors and a private consulting
practice that included the establishment of businesses and real estate
investment in the United States.


Bruce Lewis, Chairman of Biosenta commented "We are pleased to have Chris Bilz
join Biosenta's management team as his leadership skills and experience in
developing new business opportunities in the United States will help to drive
the Company's growth in key markets we are targeting in the U.S., as well as
those that we have already initiated within Canada."


About BIOSENTA Inc.

BIOSENTA Inc.'s line of retail anti-microbial products will effectively kill
mold, bacteria and fungi on contact and prevent re-growth. These products
address the demand created by the mounting health and environmental concerns.
Mold can affect the immune system, nervous system, liver, kidneys, blood and
cause brain damage.


BIOSENTA will also manufacture and distribute an anti-microbial filler. Calcium
Carbonate is one of the most common fillers used industrially. It is susceptible
like other fillers that hold moisture to attracting mold. Annual global revenue
in the calcium carbonate filler industry approximates 140 billion dollars.
BIOSENTA will produce anti-microbial filler that performs 'filling' and
'bulking' functions like calcium carbonate. BIOSENTA's filler product will not
attract moisture and consequently mold infestation. BIOSENTA's filler with its
anti-microbial high pH core in individual particles will enhance commercial
product life and eradicate a broad spectrum of known bacteria, fungi, algae and
other micro-organisms by suppression of their reproduction.


Forward-Looking Information

This release may contain forward-looking statements information and statements
which constitute "forward-looking information" under Canadian securities law and
which may be material regarding, among other things, the Company's beliefs,
plans, objectives, estimates, intentions and expectations with respect to its
capital and funding plans. Inherent in the forward-looking information and
statements are known and unknown risks, uncertainties and other factors beyond
the Company's ability to control or predict, which give rise to the possibility
that the Company's predictions, forecasts, expectations or conclusions will not
prove to be accurate, that its assumptions may not be correct and that the
Company's plans, objectives and statements will not be achieved. Actual results
or developments may differ materially from those contemplated by the
forward-looking information and statements. Consequently, undue reliance should
not placed on such forward-looking statements.


The CNSX has in no way passed upon the merits of the proposed transaction and
has neither approved nor disapproved of the contents of this press release.
Neither the CNSX nor its Regulation Services Provider (as such term is defined
in the policies of the CNSX) accepts responsibility for the adequacy or accuracy
of this release.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Biosenta, Inc.
Chris Bilz
Chief Executive Officer
(416) 410 2019


Investor Relations contact:
Investor Cubed Inc.
Neil Simon
647-258-3311 or 888-258-3323
info@investor3.ca

BIOSENTA (CSE:ZRO)
Historical Stock Chart
From Nov 2024 to Dec 2024

BIOSENTA (CSE:ZRO)
Historical Stock Chart
From Dec 2023 to Dec 2024